Back to RL Rokos Capital Management LLP

RPRXRPRX
9 quarters

Position history for RLRokos Capital Management LLP's holdings in ROYALTY PHARMA PLC- CL A

Rokos Capital Management LLP previously held 0 shares of RPRX (ROYALTY PHARMA PLC- CL A), worth $0 as of 2023-Q4.

Final Value

$0

Final Shares

0

Total Value Change

-$13.7M

Total Shares Change

-333,778

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2023-Q4
Latest
Exited
0
-100.0%
$00.0%$26.21
0
2023-Q3
Decreased
1.1M
-16.9%
$29.6M0.2%$25.14
0
2023-Q2
Increased
1.3M
+20.3%
$41M0.4%$28.28
41
2023-Q1
Increased
1.1M
+124.9%
$40.1M3.0%$32.95
80
2022-Q4
Unchanged
492,228
0.0%
$19.3M0.8%$35.95
0
2022-Q3
Unchanged
492,228
0.0%
$19.9M0.6%$36.39
0
2022-Q2
New
492,228
-
$20.6M0.6%$37.91
55
2021-Q3
Exited
0
-100.0%
$00.0%$32.15
0
2021-Q2
New
333,778
-
$13.7M0.3%$36.31
46

Other major holders of RPRX: MORGAN STANLEY, ADAGE CAPITAL PARTNERS GP, L.L.C., Capital International Investors

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used